IGM Biosciences, Inc. (DELISTED) (IGMS:DL)
1.27
0.00 (0.00%)
USD |
NASDAQ |
Aug 22, 16:00
IGM Biosciences Total Liabilities (Quarterly): 6.06M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 370.09M |
| Tango Therapeutics, Inc. | 50.10M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Theriva Biologics, Inc. | 24.10M |
| Oragenics, Inc. | 2.874M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.99M |
| Shareholders Equity (Quarterly) | 100.93M |
| Current Ratio | 17.66 |
| Net Debt Paydown Yield | 12.14% |